Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Bullboard Posts
Comment by HossBenderon Apr 18, 2019 3:03am
197 Views
Post# 29642699

RE:Mmj executives 1 mill warrants more cash for the books

RE:Mmj executives 1 mill warrants more cash for the books They also potentially contributed to the recent selloff 

"Since 31 March 2019 MMJ has taken advantage of the further substantial share price growth of MediPharm LABS Inc. (LABS) by selling down part of its investment in LABS to provide liquidity for future investments."

I would be cautious about getting in on the next run up: 


"MMJ retains a substantial investment in LABS with 2m warrants with book value of AUD9m."

I'm long on Labs, we should hopefully see some consolidation around these prices (potentially in the low to mid 4.00 range), but watch out for the next selloff on large share price runs in the future. I always get a little anxious when the chart goes parabolic. 

Good luck everyone. 
Bullboard Posts